Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T16243 | Target Info | |||
Target Name | Beta-arrestin-2 (ARRB2) | ||||
Synonyms | Non-visual arrestin-3; Betaarrestin2; Arrestin beta2; Arrestin beta-2; ARR2; ARB2 | ||||
Target Type | Literature-reported Target | ||||
Gene Name | ARRB2 | ||||
Biochemical Class | Arrestin protein | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Auxiliary transporters | [+] 1 Auxiliary transporters | + | |||
Interacting Target Name | Filamin A (FLNA) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Non-muscle filamin; Nonmuscle filamin; FLN-A; FLN1; FLN; Filamin-A; Filamin-1; Filamin 1; Endothelial actin-binding protein; Endothelial actin cytoskeleton; Alpha-filamin; Actin-binding protein 280; ABP-280 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [2] | |||
Ester hydrolases | [+] 1 Ester hydrolases | + | |||
Interacting Protein Name | Protein phosphatase 1B (PPM1B) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PP2C.beta; PP2C.beta.X; PP2CB; PP2CBETA; PPC2BETAX | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [1] | |||
3 | Co-localization | [3] | |||
G-protein-coupled receptors | [+] 1 G-protein-coupled receptors | + | |||
Interacting Target Name | Adrenergic receptor beta-2 (ADRB2) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Beta-2 adrenoreceptor; Beta-2 adrenoceptor; Beta-2 adrenergic receptor; B2AR; ADRB2R | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [4] | |||
2 | Fluorescence Resonance Energy Transfer | [5] | |||
Kinases | [+] 7 Kinases | + | |||
Interacting Target Name | Extracellular signal-regulated kinase 2 (ERK2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PRKM2; PRKM1; P42-MAPK; P42 Mitogen-activated protein kinase; Mitogen-activated protein kinase 2; Mitogen-activated protein kinase 1; MAPK 2; MAPK 1; MAP kinase isoform p42; MAP kinase 2; MAP kinase 1; ERT1; ERK-2 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [6] | |||
3 | Affinity Capture-Western | [7] | |||
4 | Co-localization | [3] | |||
Interacting Target Name | Epidermal growth factor receptor (EGFR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Epidermal growth factor receptor variant III; Proto-oncogene c-ErbB-1 variant III; Receptor tyrosine-protein kinase erbB-1 variant III; EGFR variant III; ERBB variant III; ERBB1 variant III; HER1 variant III | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Protein-Fragment Complementation Assay | [8] | |||
2 | Yeast two hybrid | [9] | |||
Interacting Target Name | RAC-alpha serine/threonine-protein kinase (AKT1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RAC-PK-alpha; RAC; Proto-oncogene c-Akt; Protein kinase B alpha; Protein kinase B; PKB alpha; PKB | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [10] | |||
2 | Reconstituted Complex | [11] | |||
Interacting Target Name | MAPK/ERK kinase kinase 1 (MAP3K1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Mitogen-activated protein kinase kinase kinase 1; Mitogenactivated protein kinase kinase kinase 1; MEKK1; MEKK 1; MEKK; MEK kinase 1; MAPKKK1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Co-localization | [3] | |||
Interacting Target Name | Stress-activated protein kinase JNK3 (JNK3) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Stress-activated protein kinase 1b; SAPK1b; PRKM10; Mitogen-activated protein kinase 10; MAPK 10; MAP kinase p49 3F12; MAP kinase 10; JNK3A; C-Jun N-terminal kinase 3 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [12] | |||
2 | Protein-peptide | [13] | |||
Interacting Target Name | Inhibitor of nuclear factor kappa-B kinase alpha (IKKA) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor 16; TCF-16; TCF16; Nuclear factor NF-kappa-B inhibitor kinase alpha; Nuclear factor NFkappaB inhibitor kinase alpha; NFKBIKA; Inhibitory kappa B kinasea; Inhibitor of nuclear factor kappa-B kinase subunit alpha; IKK-alpha; IKK-A; IKK1; IkBKA; I-kappa-B kinase alpha; I-kappa-B kinase 1; IkappaB kinase; I kappa-B kinase alpha; Conserved helix-loop-helix ubiquitous kinase | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Co-localization | [3] | |||
Interacting Protein Name | Dual specificity mitogen-activated protein kinase kinase 4 (MAP2K4) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | JNKK; JNKK1; MAPKK4; MEK4; MKK4; PRKMK4; SAPKK.1; SAPKK1; SEK1; SERK1; SKK1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [14] | |||
2 | Protein-peptide | [13] | |||
Peptidases | [+] 1 Peptidases | + | |||
Interacting Target Name | VHL-interacting deubiquitinating enzyme 1 (VDU1) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Ubiquitin-specific-processing protease 33; Ubiquitin thioesterase 33; Ubiquitin carboxyl-terminal hydrolase 33; KIAA1097; hVDU1; Deubiquitinating enzyme 33 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [15] | |||
2 | Affinity Capture-Western | [16] | |||
3 | Affinity Capture-Western | [17] | |||
4 | Reconstituted Complex | [17] | |||
5 | Yeast two hybrid | [17] | |||
Putative transporters | [+] 2 Putative transporters | + | |||
Interacting Protein Name | AP-2 complex subunit beta (AP2B1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ADTB2; AP105B; AP2.BETA; CLAPB1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [18] | |||
3 | Yeast two hybrid | [19] | |||
Interacting Protein Name | AP-3 complex subunit beta-2 (AP3B2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | NAPTB | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [20] | |||
Ubiquitin related proteins | [+] 2 Ubiquitin related proteins | + | |||
Interacting Target Name | Ubiquitin-protein ligase E3 Mdm2 (MDM2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RING-type E3 ubiquitin transferase Mdm2; P53-binding protein Mdm2; Oncoprotein Mdm2; MDM2 protein; Hdm2; E3 ubiquitin-protein ligase Mdm2; Double minute 2 protein | ||||
Evidence Score (E-score) | 9 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [21] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Affinity Capture-Western | [22] | |||
4 | Affinity Capture-Western | [23] | |||
5 | Affinity Capture-Western | [24] | |||
6 | Affinity Capture-Western | [25] | |||
7 | Affinity Capture-Western | [26] | |||
8 | Fluorescence Resonance Energy Transfer | [2] | |||
9 | Yeast two hybrid | [27] | |||
Interacting Target Name | Polyubiquitin-C (UBC) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HMG20; ubiquitin C | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Fluorescence Resonance Energy Transfer | [28] | |||
Other proteins | [+] 5 Other proteins | + | |||
Interacting Protein Name | Nucleolar and coiled-body phosphoprotein 1 (NOLC1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | NOPP130; NOPP140; NS5ATP13; P130 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [29] | |||
3 | Affinity Capture-MS | [30] | |||
4 | Affinity Capture-Western | [1] | |||
Interacting Protein Name | NF-kappa-B inhibitor alpha (NFKBIA) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | IKBA; MAD.3; NFKBI | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [31] | |||
2 | Affinity Capture-Western | [32] | |||
3 | Reconstituted Complex | [32] | |||
Interacting Protein Name | Treacle protein (TCOF1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MFD1; TCS; TCS1; treacle | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [30] | |||
3 | Affinity Capture-Western | [1] | |||
Interacting Protein Name | Catenin alpha-1 (CTNNA1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CAP102 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Co-localization | [3] | |||
Interacting Protein Name | Src substrate cortactin (CTTN) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | EMS1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Co-localization | [3] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12011-6. | ||||
REF 2 | beta-arrestin 2 oligomerization controls the Mdm2-dependent inhibition of p53. Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18061-6. | ||||
REF 3 | Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network. J Proteome Res. 2014 Dec 5;13(12):5339-46. | ||||
REF 4 | CHIP-MYTH: a novel interactive proteomics method for the assessment of agonist-dependent interactions of the human adrenergic receptor. Biochem Biophys Res Commun. 2014 Mar 21;445(4):746-56. | ||||
REF 5 | The -Arrestin ARRDC3 Regulates the Endosomal Residence Time and Intracellular Signaling of the 2-Adrenergic Receptor. J Biol Chem. 2016 Jul 8;291(28):14510-25. | ||||
REF 6 | Receptor-specific ubiquitination of beta-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes. J Biol Chem. 2005 Apr 15;280(15):15315-24. | ||||
REF 7 | Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2449-54. | ||||
REF 8 | The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions in human cells. Nat Methods. 2014 May;11(5):585-92. | ||||
REF 9 | In silico prediction of physical protein interactions and characterization of interactome orphans. Nat Methods. 2015 Jan;12(1):79-84. | ||||
REF 10 | c-Src regulates Akt signaling in response to ghrelin via beta-arrestin signaling-independent and -dependent mechanisms. PLoS One. 2009;4(3):e4686. | ||||
REF 11 | A beta-arrestin 2 signaling complex mediates lithium action on behavior. Cell. 2008 Jan 11;132(1):125-36. | ||||
REF 12 | Identification of a motif in the carboxyl terminus of beta -arrestin2 responsible for activation of JNK3. J Biol Chem. 2001 Jul 27;276(30):27770-7. | ||||
REF 13 | A scanning peptide array approach uncovers association sites within the JNK/beta arrestin signalling complex. FEBS Lett. 2009 Oct 20;583(20):3310-6. | ||||
REF 14 | Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science. 2000 Nov 24;290(5496):1574-7. | ||||
REF 15 | The deubiquitinases USP33 and USP20 coordinate beta2 adrenergic receptor recycling and resensitization. EMBO J. 2009 Jun 17;28(12):1684-96. | ||||
REF 16 | Deubiquitinases and their emerging roles in -arrestin-mediated signaling. Methods Enzymol. 2014;535:351-70. | ||||
REF 17 | Beta-arrestin-dependent signaling and trafficking of 7-transmembrane receptors is reciprocally regulated by the deubiquitinase USP33 and the E3 ligase Mdm2. Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6650-5. | ||||
REF 18 | Small ubiquitin-like modifier modification of arrestin-3 regulates receptor trafficking. J Biol Chem. 2011 Feb 4;286(5):3884-93. | ||||
REF 19 | The beta2-adrenergic receptor/betaarrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3712-7. | ||||
REF 20 | Regulation of arrestin-3 phosphorylation by casein kinase II. J Biol Chem. 2002 May 10;277(19):16837-46. | ||||
REF 21 | Beta-arrestin 2 functions as a G-protein-coupled receptor-activated regulator of oncoprotein Mdm2. J Biol Chem. 2003 Feb 21;278(8):6363-70. | ||||
REF 22 | Nedd4 mediates agonist-dependent ubiquitination, lysosomal targeting, and degradation of the beta2-adrenergic receptor. J Biol Chem. 2008 Aug 8;283(32):22166-76. | ||||
REF 23 | Ubiquitin ligase parkin promotes Mdm2-arrestin interaction but inhibits arrestin ubiquitination. Biochemistry. 2011 May 10;50(18):3749-63. | ||||
REF 24 | Intact MDM2 E3 ligase activity is required for the cytosolic localization and function of -arrestin2. Mol Biol Cell. 2011 May;22(9):1608-16. | ||||
REF 25 | {beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase. J Biol Chem. 2005 Jul 1;280(26):24412-9. | ||||
REF 26 | Multiple scaffolding functions of {beta}-arrestins in the degradation of G protein-coupled receptor kinase 2. J Biol Chem. 2011 Jan 14;286(2):1165-73. | ||||
REF 27 | Toward an understanding of the protein interaction network of the human liver. Mol Syst Biol. 2011 Oct 11;7:536. | ||||
REF 28 | Temporal profiling of orexin receptor-arrestin-ubiquitin complexes reveals differences between receptor subtypes. J Biol Chem. 2011 May 13;286(19):16726-33. | ||||
REF 29 | Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509. | ||||
REF 30 | Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol. 2007;3:89. | ||||
REF 31 | beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha. Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8603-7. | ||||
REF 32 | Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways. Mol Cell. 2004 May 7;14(3):303-17. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.